Related Experiment Videos
Balancing physician and cost-containment demands
F Randy Vogenberg1, Leo K Lichtig, Richard M Weinberg
1Aon Consulting's Life Sciences, Wellesley, Mass, USA. randy_vogenberg@aoncons.com
Summary
Clinicians and CFOs face medication choices. Reliable data on the total cost of care is essential for selecting appropriate medications, balancing new drug benefits with older drug costs.
Area of Science:
- Pharmacoeconomics
- Health Services Research
- Clinical Decision-Making
Background:
- Clinicians may favor new medications for perceived ease of use, safety, and better outcomes.
- Financial stakeholders (CFOs) might prefer older, lower-cost medications.
- Conflicting perspectives can hinder optimal medication selection.
Purpose of the Study:
- To emphasize the critical need for comprehensive data in medication selection.
- To highlight the importance of evaluating the total cost of care.
- To guide physicians and CFOs toward evidence-based medication choices.
Main Methods:
- Analysis of factors influencing clinician and CFO medication preferences.
- Review of data requirements for assessing total cost of care.
- Discussion of methodologies for comparative medication cost-effectiveness.
Main Results:
- Both new and older medications present distinct advantages and disadvantages.
- Subjective assessments of medication benefits and costs can be misleading.
- Objective data on total patient care costs are often lacking but crucial.
Conclusions:
- Accurate measurement of the total cost of care is vital for informed medication decisions.
- Integrating clinical and financial data supports optimal medication selection.
- Evidence-based approaches are necessary to overcome biased perspectives in healthcare economics.